Ekso Bionics Announces Partnership with U.S. Physiatry to Support Physician Education of EksoNR
09 mars 2021 08h00 HE
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., March 09, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
Ekso Bionics Teams Up with Performance Contracting, Inc. for Innovative Testing Approach of EVO™ Technology
03 mars 2021 08h00 HE
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., March 03, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
Ekso Bionics to Present at the H.C. Wainwright Global Life Sciences Conference
02 mars 2021 08h00 HE
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that...
Ekso Bionics Reports Fourth Quarter and Year End 2020 Results
25 févr. 2021 16h05 HE
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
Ekso Bionics® to Report Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021
18 févr. 2021 08h00 HE
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that it...
Ekso Bionics Announces Closing of $40 Million Bought Deal Offering
11 févr. 2021 16h35 HE
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (“Ekso Bionics”), an industry leader in exoskeleton technology for medical and industrial use, today...
Ekso Bionics Increases Previously Announced Bought Deal Offering of Common Stock to $40 Million
08 févr. 2021 23h30 HE
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (“Ekso Bionics”), an industry leader in exoskeleton technology for medical and industrial use, today...
Ekso Bionics Announces $10 Million Bought Deal Offering Of Common Stock
08 févr. 2021 17h11 HE
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (“Ekso Bionics”), an industry leader in exoskeleton technology for medical and industrial use, today...
Ekso Bionics Reports Preliminary Fourth Quarter and Full Year 2020 Financial Results
13 janv. 2021 16h05 HE
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., Jan. 13, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced...
Ekso Bionics to Present at the H.C. Wainwright BioConnect 2021 Conference
05 janv. 2021 08h00 HE
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that Jack...